Modified Amine Lipids for CRISPR Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current compositions for delivering CRISPR/Cas gene editing components, such as mRNA encoding the CRISPR protein component and CRISPR guide RNAs, into cells are inadequate for effective in vitro and in vivo delivery.

Innovation Solution

The use of amine-containing lipids to formulate lipid nanoparticle (LNP) compositions that facilitate the delivery of CRISPR/Cas gene editing components into cells, specifically through the formulation of compounds according to structures such as Formula (IA) and (I).

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional delivery compositions are used, then delivery of CRISPR/Cas components to cells is attempted, but delivery effectiveness is inadequate

Engineering Contradiction:
Improvedelivery effectivenessVSAvoidgene editing efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent modifies the chemical structure of ionizable lipids by changing parameters such as the hydrophobic region (varying carbon chain lengths and unsaturation), the hydrophilic region (different amine groups and linkers), and the overall molecular weight. These parameter changes optimize the lipid's ability to form LNPs and deliver CRISPR/Cas components effectively into cells, resolving the contradiction between delivery reliability and gene editing efficiency

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates composite lipid structures combining hydrophobic fatty acid chains with hydrophilic amine-containing head groups. These composite ionizable lipids self-assemble with nucleic acids to form lipid nanoparticle complexes that effectively deliver CRISPR/Cas components into cells, transforming the inadequate conventional delivery into effective gene editing delivery

Inventive Principle:
Principle #40Composite materials

2Reliability

If LNP compositions are formulated with modified ionizable lipids, then delivery effectiveness is improved, but lipid structure complexity increases

Engineering Contradiction:
Improvedelivery effectivenessVSAvoidlipid structure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The ionizable lipids are segmented into distinct functional regions: a hydrophobic fatty acid region (with specific chain lengths and unsaturation levels) and a hydrophilic amine-containing head group region (with specific linkers and basic groups). This segmentation allows each region to perform its specific function optimally while maintaining overall molecular manageability, improving delivery effectiveness without excessive complexity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The ionizable lipid structure is designed to perform multiple functions: forming amphipathic structures for membrane interaction, self-assembling with nucleic acids into LNPs, facilitating cellular uptake, and enabling endosomal escape. This multi-functionality is achieved through a unified molecular design that combines hydrophobic and hydrophilic regions with specific amine groups, improving delivery effectiveness while avoiding unnecessary structural complexity

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20250074866A1Modified amine lipids
Publication Date: 2025.03.06 INTELLIA THERAPEUTICS INC
  • US20250074866A1 patent drawing
  • US20250074866A1 patent drawing
  • US20250074866A1 patent drawing

AI summary

The disclosure provides ionizable amine lipids and salts thereof (e.g., pharmaceutically acceptable salts thereof) useful for the delivery of biologically active agents, for example delivering biologically active agents to cells to prepare engineered cells. The ionizable amine lipids disclosed herein are useful as ionizable lipids in the formulation of lipid nanoparticle-based compositions.